<p>In this episode, AI hosts unpack the significance of GLP-1 receptor agonists in managing metabolic health and their broader societal impacts. From issues of inequitable access and profit-driven motives to envisioning systemic healthcare reforms, we analyze how these drugs highlight systemic gaps and opportunities for a prevention-focused, equitable healthcare framework.</p>

In this episode, AI hosts unpack the significance of GLP-1 receptor agonists in managing metabolic health and their broader societal impacts. From issues of inequitable access and profit-driven motives to envisioning systemic healthcare reforms, we analyze how these drugs highlight systemic gaps and opportunities for a prevention-focused, equitable healthcare framework.

GLP-1s, Metabolic Health, and Systemic Change

Everyone knows that we need to transform our health system. It's time that we do it. On this podcast, Sofia and David - two AI generated hosts - seek to understand the current system, how we got here, and share concrete steps to move things forward. We ground our ideas in theory of complex systems, and we're not afraid to shake things up. This AI podcast was created, and is managed by Dr. Chad Swanson, an emergency physician. chadswanson.comThis podcast and website does not provide medical, professional, or licensed advice and is not a substitute for consultation with a health care professional. You should seek medical advice from a qualified health care professional for any questions. Do not use this podcast for medical diagnosis or treatment. None of the content on this website represents or warrants that any particular device, procedure, or treatment is safe, appropriate or effective for you.

Share GLP-1s, Metabolic Health, and Systemic Change

Sign up to save your podcasts

GLP-1s, Metabolic Health, and Systemic Change

GLP-1s, Metabolic Health, and Systemic Change